CS212347B2 - Method of preparation of the d-sesquisodium salt x diacid oxa- betha - lactane - Google Patents

Method of preparation of the d-sesquisodium salt x diacid oxa- betha - lactane Download PDF

Info

Publication number
CS212347B2
CS212347B2 CS802746A CS274680A CS212347B2 CS 212347 B2 CS212347 B2 CS 212347B2 CS 802746 A CS802746 A CS 802746A CS 274680 A CS274680 A CS 274680A CS 212347 B2 CS212347 B2 CS 212347B2
Authority
CS
Czechoslovakia
Prior art keywords
salt
diacid
sesquisodium
oxa
acetone
Prior art date
Application number
CS802746A
Other languages
Czech (cs)
English (en)
Inventor
William J Wheeler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS212347B2 publication Critical patent/CS212347B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS802746A 1979-04-24 1980-04-18 Method of preparation of the d-sesquisodium salt x diacid oxa- betha - lactane CS212347B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/032,840 US4259485A (en) 1979-04-24 1979-04-24 Crystallization process

Publications (1)

Publication Number Publication Date
CS212347B2 true CS212347B2 (en) 1982-03-26

Family

ID=21867102

Family Applications (1)

Application Number Title Priority Date Filing Date
CS802746A CS212347B2 (en) 1979-04-24 1980-04-18 Method of preparation of the d-sesquisodium salt x diacid oxa- betha - lactane

Country Status (34)

Country Link
US (1) US4259485A (bg)
EP (1) EP0018760B1 (bg)
JP (1) JPS55143992A (bg)
KR (1) KR840000036B1 (bg)
AR (1) AR225174A1 (bg)
AT (1) AT368158B (bg)
AU (1) AU531272B2 (bg)
BE (1) BE882849A (bg)
BG (1) BG34904A3 (bg)
CA (1) CA1124236A (bg)
CH (1) CH645901A5 (bg)
CS (1) CS212347B2 (bg)
DD (1) DD150205A5 (bg)
DE (1) DE3067412D1 (bg)
DK (1) DK172880A (bg)
EG (1) EG14334A (bg)
ES (1) ES490828A0 (bg)
FI (1) FI801252A (bg)
FR (1) FR2455043A1 (bg)
GB (1) GB2047703B (bg)
GR (1) GR68048B (bg)
HU (1) HU182127B (bg)
IE (1) IE49703B1 (bg)
IL (1) IL59895A (bg)
IT (1) IT1141294B (bg)
LU (1) LU82384A1 (bg)
NZ (1) NZ193482A (bg)
PH (1) PH15146A (bg)
PL (1) PL124423B1 (bg)
PT (1) PT71115A (bg)
RO (1) RO79315A (bg)
SU (1) SU925251A3 (bg)
YU (1) YU108180A (bg)
ZA (1) ZA802329B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103185A (en) * 1980-01-22 1981-08-18 Shionogi & Co Ltd Malonamidoxa-dethia-cephem compound
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
RU2555360C2 (ru) * 2012-11-06 2015-07-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ определения воды в координационных соединениях

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
CA1100962A (en) * 1977-04-28 1981-05-12 Yoshio Hamashima Haloarylmalonamidooxacephalosporins
JPS609718B2 (ja) * 1977-08-25 1985-03-12 塩野義製薬株式会社 チアジアゾリルチオセフアロスポリン類縁抗生物質
BE871213R (fr) * 1978-10-12 1979-02-01 Shionogi & Co Arylmalonamido-1-oxadethiacephalosporines

Also Published As

Publication number Publication date
CA1124236A (en) 1982-05-25
LU82384A1 (fr) 1980-07-31
IT1141294B (it) 1986-10-01
DE3067412D1 (en) 1984-05-17
AU5763380A (en) 1980-10-30
FR2455043B1 (bg) 1983-08-05
EG14334A (en) 1983-12-31
JPS6242915B2 (bg) 1987-09-10
NZ193482A (en) 1982-03-23
GB2047703A (en) 1980-12-03
IE800804L (en) 1980-10-24
PL223649A1 (bg) 1981-02-13
US4259485A (en) 1981-03-31
KR830002778A (ko) 1983-05-30
AR225174A1 (es) 1982-02-26
DK172880A (da) 1980-10-25
ZA802329B (en) 1981-11-25
AU531272B2 (en) 1983-08-18
DD150205A5 (de) 1981-08-19
FR2455043A1 (fr) 1980-11-21
YU108180A (en) 1983-02-28
BG34904A3 (bg) 1983-12-15
EP0018760B1 (en) 1984-04-11
RO79315A (ro) 1982-08-17
HU182127B (en) 1983-12-28
AT368158B (de) 1982-09-27
KR840000036B1 (ko) 1984-01-28
SU925251A3 (ru) 1982-04-30
IT8021527A0 (it) 1980-04-21
ATA207380A (de) 1982-01-15
JPS55143992A (en) 1980-11-10
FI801252A (fi) 1980-10-25
IL59895A (en) 1983-05-15
ES8200110A1 (es) 1981-10-16
GB2047703B (en) 1983-04-20
PT71115A (en) 1980-05-01
BE882849A (fr) 1980-10-20
GR68048B (bg) 1981-10-29
CH645901A5 (fr) 1984-10-31
EP0018760A1 (en) 1980-11-12
IE49703B1 (en) 1985-11-27
PH15146A (en) 1982-08-24
ES490828A0 (es) 1981-10-16
PL124423B1 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
CS220790B2 (en) Method of separation of the -6-methoxy-alpha-methyl-2-naphtalene vinegar acid from the mixtures of the a/-/-6-methoxy-alpha-methyl-2/naphtalene vinegar acid or salts thereof
NL192266C (nl) Werkwijze voor het bereiden van een kristallijn cefepime-dihydrochloride alsmede het kristallijne dihydrochloride en mengsels die het bevatten.
EP0112550B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
US4727065A (en) Bis-(2-ammonium-2-hydroxymethyl-1,3-propanediol(2R-cis)-(3-methyloxiranyl)-phosphonate, a method of preparing same, and pharmaceutical compositions containing same
CS212347B2 (en) Method of preparation of the d-sesquisodium salt x diacid oxa- betha - lactane
AT392643B (de) Verfahren zur herstellung von neuen derivaten der 7-(d-2-amino-2-(4-hydroxyphenyl)-acetamido)-3- ((z)-1-propenyl)ceph-3-em-4-carbonsaeure
EP0027597A1 (en) Mono(2-ammonium-2-hydroxymethyl-1,3-propanediol)(2R-cis)-(3-methyloxiranyl)phosphonate, its preparation and pharmaceutical compositions containing it
CZ266697A3 (en) Salts of clavulanic acid
HU193534B (en) Process for producing salts of n-/phosphono-methyl/-glycine
SU860705A3 (ru) Способ получени кристаллической формы D-конфигурации диаммониевой соли 7 - -карбокси- -( -оксифенил)ацетамидо/-7 -метокси-3-(1-метилтетразол-5-ил)-тиометил-1-оксадетиа-3-цефем-4-карбоновой кислоты
US4791196A (en) Crystalline cephem carboxylic acid addition salt
EP0261823A1 (en) Stable hydrate of penicillin derivative and process for preparing same
JPH0157115B2 (bg)
HU180161B (en) Process for preparing crystalline,stable prostaglandin f down 2alpha with a melting point over 35 c from contaminated prostaglandin f down 2alpha containing 50-98% prostaglandin f down 2alpha
GB2129429A (en) B-lactam antibiotics
IE45684B1 (en) Crystallised potassium salt of adenosine5-5'-diphosphoric acid and process for its preparation